Healius Limited · ASX:HLS
Bruce Robinson bought 109,890 Healius Limited shares (Appendix 3Y, ASX)
Traded Oct 28, 2026 · Filed Nov 20, 2026
On Oct 28, 2026, Bruce Robinson (Director) bought 109,890 Healius Limited shares at AUD 0.46 for AUD 50,549. Filed Nov 20, 2026 (Appendix 3Y, ASX).
- Bought
- 109,890 shares
- Price
- AUD 0.46
- Value
- AUD 50,549
- Role
- Director
The filing in full
ASX Announcement
20 November 2026
ASX Limited
Market Announcements Office
39 Martin Place
SYDNEY NSW 2000
Re: Healius Limited (‘HLS’): Late lodgement of Appendix 3Y – Bruce Robinson
Healius Limited (ASX: HLS) (Company) attaches an Appendix 3Y, Change of Director's Interest Notice, in respect
of Bruce Robinson.
The Appendix 3Y was not lodged within the five-business-day timeframe required under ASX Listing Rule 3.19A.2.
Following consultation with ASX, ASX has directed the Company under Listing Rule 18.8 to provide the following
information.
1. Reason for late lodgement
The Appendix 3Y was lodged late because, as the result of an administrative oversight on the part of the Director,
the Company was not notified of the relevant transaction within the required timeframe. The Company became
aware of the transaction on 20 November 2026 and lodged the Appendix 3Y promptly after becoming aware of it.
2. Arrangements under Listing Rule 3.19B
The Company has arrangements in place with its Directors to enable it to comply with its disclosure obligations
under Listing Rule 3.19A. These include:
• a Board-approved Policy on Trading in Healius Securities, which is publicly available on the Company's
website, and which applies specific requirements and restrictions to Directors and Key Management Personnel,
procedures requiring Directors to promptly notify the Company Secretary of any acquisition, disposal, transfer
or other change in their notifiable interests and provide the information required to enable the Company to
prepare and lodge the relevant Appendix 3Y, with the declaration of Directors’ interests also being a standing
agenda item at each Board meeting, and
• periodic guidance provided to Directors regarding their disclosure obligations, including the requirement for the
Company to lodge an Appendix 3Y within five business days of a change in a Director's notifiable interests.
3. Additional steps
The Company considers that its existing arrangements are appropriate. However, following this incident, the
Company will provide refresher training to all Directors regarding their notification obligations and the Company's
securities trading arrangements, and reinforce the importance of promptly providing the Company Secretary with all
information necessary to enable the Company to meet its disclosure obligations under the ASX Listing Rules.
This announcement has been authorised for release by the Managing Director and CEO.
---
For further information please contact:Investor EnquiriesMedia EnquiriesAndrew ThomsonSusannah RandsChief Financial OfficerHead of CommunicationsHealius LimitedHealius Limitedinvestor.relations@healius.com.aumedia@healius.com.au
About Healius Limited
*For over 30 years Healius has been one of Australia’s leading healthcare companies, committed to supporting
quality, affordable and accessible healthcare for all Australians. Through its unique footprint of centres and its*
*8,500+ employees, Healius provides Australia-wide specialty pathology services to consumers and their referring
practitioners.*
2 of 2
---
*Rule 3.19A.2*
Appendix 3Y
Change of Director’s Interest Notice
*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*
Introduced 30/09/01 Amended 01/01/11
| Name of entity | HEALIUS LIMITED |
|---|---|
| ABN | 24 064 530 516 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Bruce Robinson |
|---|---|
| Date of last notice | 2 February 2026 |
Part 1 - Change of director’s relevant interests in securities
*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Bruce Gregory Robinson & Alice Ruth Killen Superannuation Fund. Bruce Robinson is a member and beneficiary of the fund. |
| Date of change | 28 October 2026 |
| No. of securities held prior to change | Nil |
| Class | Fully paid ordinary shares |
| Number acquired | 109,890 |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Average price of $0.460 per share |
---
| No. of securities held after change | 109,890 fully paid ordinary shares (Indirect) |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | On market trade |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
| Detail of contract | Nil |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
| Interest after change | N/A |
+ Part 3 – Closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? | - |
| If prior written clearance was provided, on what date was this provided? | - |
Authorised by: Kylie Brown, Company Secretary
Date: 20 November 2026
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Fully paid ordinary shares | Buy | 109,890 | AUD 0.46 |
Source
Download PDF · View original at ASX
Related
- Healius Limited
- Bruce Robinson
- Healius Limited shareholders
- Substantial holder notice (ASX) · Host-Plus Pty Limited · Nov 19, 2026
- Appendix 3Y (ASX) · Paul Anderson · Nov 18, 2026
- Substantial holder notice (ASX) · Host-Plus Pty Limited · Nov 17, 2026
- Substantial holder notice (ASX) · Tanarra Entities) · Nov 16, 2026
- Appendix 3Y (ASX) · Paul Anderson · Oct 27, 2026